Clinical and biological considerations regarding glioma based on the TUNEL method and immunohistochemical staining using apoptosis-related antibodies.

Brain tumor pathology

Volumn 14, Issue 2, 1997, Pages 97-102

  Fujita, T ^a   Kayama, T ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; FAS ANTIGEN; LEWIS Y ANTIGEN;

APOPTOSIS; ARTICLE; BLOOD GROUP LEWIS SYSTEM; CENTRAL NERVOUS SYSTEM TUMOR; DISEASE COURSE; GLIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METHODOLOGY; NICK END LABELING; PATHOLOGY; PATHOPHYSIOLOGY; STAINING;

ANTIBODIES; ANTIGENS, CD95; APOPTOSIS; CENTRAL NERVOUS SYSTEM NEOPLASMS; DISEASE PROGRESSION; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LEWIS BLOOD-GROUP SYSTEM; STAINING AND LABELING;

EID: 12244304746     PISSN: 14337398     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02478877     Document Type: Article

References (0)